- Nachrichtendetail
-
09.04.2024 12:50:53 - dpa-AFX: *PFIZER SAYS PHASE 3 ABRYSVO STUDY MEETS TRIAL PRIMARY ENDPOINTS
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
Pfizer | 852009 | NYSE | 29,310 | 03.06.24 22:01:10 | +0,650 | +2,27% | 29,270 | 29,280 | 28,660 | 28,660 |
